mm

About Jason Novak

Jason has been a consistent contributor to VectorVest and has a blended interest in technology and finance, which he has written about for over a decade. When he's not demystifying complex financial topics or sharing a quick analysis of hot stocks on a given day, you may find him on the golf course or exploring all that Northern California has to offer.
17 09, 2024

What Tupperware’s Bankruptcy Announcement Means for Investors

By |2024-09-17T18:25:40+00:00September 17th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Tupperware Brands (TUP) lost almost all of its value overnight after the company announced it would be filing for bankruptcy. The stock sat at $1.19 per share but has plummeted 57% to just $0.5 per share this morning. Exchanges like Robinhood have halted trading on the stock since. It’s been a tumultuous stretch for [...]

16 09, 2024

Intel Gets $3.5 Billion Grant From US Department of Defense, But Still Time to Sell INTC – Here’s Why…

By |2024-09-17T15:46:27+00:00September 16th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , , |

Shares of Intel Corporation (INTC) are up nearly 4% through Monday morning so far after news broke of the company’s $3.5 billion grant awarded under the “Secure Enclave” program by the US Department of Defense. These funds will be used to produce advanced semiconductors which will then be used for our country’s strategic defense [...]

15 09, 2024

What is Rolling Covered Calls? When to Roll Covered Calls

By |2024-09-09T23:58:51+00:00September 15th, 2024|Categories: Options|Tags: , , |

There’s nothing worse than seeing the trade you’d envisioned start to take a turn for the worse, falling apart right before your eyes. While much of this can be prevented with a sound strategy and the help of our stock analysis software, selling covered calls won’t always work out how you’d planned. With traditional stock [...]

13 09, 2024

Adobe’s Weak Guidance Overshadows Strong Q3 Results: 3 Other Things Investors Need to Consider

By |2024-09-17T15:46:31+00:00September 13th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , |

Adobe Inc. (ADBE) reported third-quarter earnings yesterday after the market closed, and while earnings and revenue both came in above the analyst consensus, the focus remained on lackluster guidance for the current quarter. Here’s how the company performed in Q3: Adjusted earnings per share: $4.65 compared to the $4.53 consensus. Revenue: $5.41 billion compared [...]

12 09, 2024

Cash Secured Put vs Covered Call: What’s the Difference and Which Strategy Should You Use?

By |2024-09-09T23:58:39+00:00September 12th, 2024|Categories: Options|Tags: , , |

From the basic differences between a call vs put to more nuanced strategies like long calls vs covered calls, there are so many different ways to navigate the options trading realm. But today, we’re going to put two very similar, yet different, strategies side by side: cash secured put vs covered call. A cash-secured put [...]

12 09, 2024

Lovesac Stock Jumps 25% on Q2 Earnings Results, But Is This Reason Enough to BUY LOVE?

By |2024-09-17T15:46:35+00:00September 12th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , |

Lovesac Co. (LOVE) has gained more than 24% so far Thursday morning after delivering a somewhat mixed bag for the second quarter of fiscal 2025. The company saw sales climb, yet profits shrunk.  Still, the company managed to beat the analyst expectations on both the top and bottom lines for Q2. The loss of [...]

11 09, 2024

The Presidential Debate is Affecting Trump’s Media Company: 3 Things DJT Investors Need to See

By |2024-10-21T16:46:24+00:00September 11th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

The debate America has long been anticipating took place last night between former president Donald Trump and current Vice President Kamala Harris.  The general consensus as of Wednesday morning is that Trump put on a somewhat rocky performance, with many believing Harris performed better than expected. Even conservative voters aren’t thrilled with what they [...]

10 09, 2024

What the EU’s Court Verdict Means for Apple: Plus, 3 Other Things for AAPL Investors to Consider

By |2024-10-21T16:46:32+00:00September 10th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

It was a bad day for tech companies in the European Union (EU) court system as both Apple (AAPL) and Google (GOOGL) lost their battles and will face hefty financial penalties as a result. Apple was fighting a €13 billion ($14.4 billion) Irish tax bill, which can be traced all the way back to [...]

9 09, 2024

Average Return Selling Covered Calls

By |2024-09-09T23:58:45+00:00September 9th, 2024|Categories: Options|Tags: , , |

Of all the different ways to make money with options, selling covered calls has become increasingly popular for its consistency and ease of implementation. It’s a great way to earn supplemental income on a stock you own that isn’t moving much. But, let’s get more specific. What is the average return selling covered calls? A [...]

6 09, 2024

Vaxcyte Trial Results Suggest it Could Compete With Pfizer: Is it Worth Buying This Stock Today?

By |2024-09-06T17:12:21+00:00September 6th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Earlier this week Vaxcyte (PCVX) shared an update on its VAX-31 trial results, which are quite promising. The stock popped nearly 50% on the news, sending shares to an all-time high of $115/share.  VAX-31 is the company’s pneumococcal conjugate vaccine. This disease can contribute to more serious illnesses such as pneumonia, meningitis, and various [...]

Go to Top